SM

Seiji Miyahara

Partner & Senior Investment Director at Taiho Ventures

Menlo Park, California

Overview 

Seiji Miyahara is a Partner & Senior Investment Director at Taiho Ventures, LLC in Menlo Park, California, with a background in Venture Capital and extensive experience in the life sciences and biotechnology sectors. Notable highlights include serving on the Board of Directors for various companies and contributing to the growth of start-ups in the San Francisco Bay Area.

Work Experience 

Taiho Ventures, LLC

  • Partner & Senior Investment Director

    2024 - Current

  • Senior Investment Director

    2021 - 2024

  • Investment Director

    2019 - 2021

  • Associate Investment Director

    2016 - 2018

E

EpiBiologics

  • Board Member

    2023

EpiBiologics develops antibody-based targeted therapies against membrane and extracellular proteins.

Raised $96,050,000.00 from Google Ventures, Digitalis Ventures, Vivo Capital, Polaris Partners, Taiho Ventures, Codon Capital, Mubadala Capital Ventures, Polaris Partners, Mubadala Capital Ventures and Google Ventures.

epibiologics.com
hB

hC Bioscience, Inc.

  • Board Member

    2022

HC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.

Raised $40,000,000.00 from ARCH Venture Partners, 8VC, Panacea Venture, Taiho Ventures, Takeda Ventures, ARCH Venture Partners, 8VC and Takeda Ventures.

hcbioscience.com
TB

Transition Bio, Inc.

  • Board Observer

    2022

Transition Bio provides condensate technology for drug discovery and diagnostics.

Raised $63,265,426.00 from Bristol-Myers Squibb, Northpond Ventures, Taiho Ventures, Magnetic Ventures and Lifeforce Capital.

transitionbio.com
AT

Anavo Therapeutics BV

  • Board Observer

    2020

T

Theolytics

  • Board Observer

    2020

BT

Breakpoint Therapeutics GmbH

  • Board Observer

    2019

Taiho Pharmaceutical Co., Ltd.,

  • Research Fellow

    2004 - 2016

Education 

Articles About Seiji

Relevant Websites